Anti-biofi lm agents in control of device-related infections

Advances in Experimental Medicine and Biology

Volumn 831, Issue , 2015, Pages 137-146

  Ahmed, Salman ^a   Darouiche, Rabih O ^a  

^a BAYLOR COLLEGE OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

2 AMINOIMIDAZOLE; ACETYLCYSTEINE; ANTIINFECTIVE AGENT; DAPTOMYCIN; DEOXYRIBONUCLEASE I; DISPERSIN B; EDETIC ACID; FURANONE; LINEZOLID; MINOCYCLINE; RIFAMPICIN; STAPHYLOCOCCUS EPIDERMIDIS BACTERIOPHAGE 456; STREPTOCOCCUS SUIS LYTIC PHAGE; TIGECYCLINE; UNCLASSIFIED DRUG; VANCOMYCIN;

ANEMIA; ARTICLE; BACTERICIDAL ACTIVITY; BIOFILM; CATHETER INFECTION; DEVICE INFECTION; DRUG ABSORPTION; DRUG BLOOD LEVEL; DRUG HALF LIFE; DRUG MECHANISM; HUMAN; INFECTION CONTROL; INFECTION PREVENTION; INFECTION RISK; JOINT PROSTHESIS; KNEE IMPLANT; NONHUMAN; PRIORITY JOURNAL; PROSTHESIS INFECTION; RISK REDUCTION; THROMBOCYTOPENIA; BACTERIA; BACTERIOPHAGE; CATHETER-RELATED INFECTIONS; CLASSIFICATION; DRUG EFFECTS; GROWTH, DEVELOPMENT AND AGING; MICROBIAL CONSORTIUM; MICROBIOLOGY; PHYSIOLOGY; PROSTHESIS-RELATED INFECTIONS; VIROLOGY;

ANTI-BACTERIAL AGENTS; BACTERIA; BACTERIOPHAGES; BIOFILMS; CATHETER-RELATED INFECTIONS; HUMANS; MICROBIAL CONSORTIA; PROSTHESIS-RELATED INFECTIONS;

EID: 84926654054     PISSN: 00652598     EISSN: 22148019     Source Type: Book Series    
DOI: 10.1007/978-3-319-09782-4_9     Document Type: Article

References (62)

1. Anguita-Alonso P, Rouse MS, Piper KE, Jacofsky DJ, Osmon DR, Patel R (2006) Comparative study of antimicrobial release kinetics from polymethylmethacrylate. Clin Orthop Rel Res 445: 239-244
2. Antoci V Jr, Adams CS, Hickock NJ, Shapiro IM, Parvizi J (2007) Vancomycin bound to Ti rods reduces periprosthetic infection: preliminary study. Clin Orthopedic Relat Res 461: 88-95
3. Archer GL, Johnston JL, Vazquez GJ, Haywood HB (1983) Efficacy of antibiotic combinations including rifampin against methicillin-resistant Staphylococcus epidermidis: in vitro and in vivo studies. Rev Infect Dis 5 (Suppl 3): S538
4. Arciola CR, Montanaro L, Costerton JW (2011) New trends in diagnosis and control strategies for implant infections. Int J Artif Organs 34 (9): 727-736
5. Aslam S (2008) Effects of antibacterials on biofilms. Am J Infect Control 36: S175e9-S175e11
6. Aslam S, Darouiche RO (2011) Role of antibiofilmantimicrobial agents in control of device related infections. Int J Artif Organs 34 (9): 752-758
7. Aslam S, Trautner BW, Ramanathan V, Darouiche RO (2007) Pilot trial of N-acetylcysteine and tigecycline as a catheter-lock solution for treatment of hemodialysis catheter-associated bacteremia. Infect Control Hosp Epidemiol 29 (9): 894-897
8. Aubrey-Damon H, Soussy CJ, Courvalin P (1998) Characterization of mutations in rpoB gene that confer rifampin resistance in Staphylococcus aureus. Antimicrob Agents Chemother 42: 2590-2594
9. Aybar Y, Ozaras R, Besirli K, Engin E, Karabulut E, Salihoglu T, Mete B, Tabak F, Mert A, Tahan G, Yilmaz MH, Ozturk R (2012) Efficacy of tigecycline and vancomycin in experimental catheter-related Staphylococcus epidermidis infection: microbiological and electron microscopic analysis of biofilm. Int J Antimicrob Agents 39: 338-342
10. Balaban N, Cirioni O, Giacometti A, Ghiselli R, Braunstein JB, Silvestri C, Mocchegiani F, Saba V, Scalise G (2007) Treatment of Staphylococcus aureus biofilm infection by the quorum-sensing inhibitor RIP. Antimicrob Agents Chemother 51: 2226-2229
11. Bernthal NM, Stavrakis AI, Billi F, Cho JS, Kremen TJ, Simon SI, Cheung AL, Finerman GA, Liberman JR, Adams JS, Miller LS (2010) A mouse-model of postarthroplasty Staphylococcus aureus joint infection to evaluate in vivo the efficacy of antimicrobial implant coatings. PLoS One 5 (9): e12580
12. Bloom HL, Constantin L, Dan D, DeLurgio DB, El-Chami M, Ganz L, Gleed KJ, Hackett K, Kanuru NK, Lerner DJ, Rasekh A, Simons GR, Sogade FO, Sohail MR (2011) Implantation success and infection in cardiovascular implantable electronic device procedures utilizing an antibacterial envelope. Pacing Clin Electrophysiol 34: 133-142
13. Campbell EA, Korzheva N, Mustaev A, Murakami K, Nair S, Goldfarb A, Darst SA (2001) Structural mechanism of rifampicin inhibition of bacterial RNA polymerase. Cell 104 (6): 901-912
14. Chaignon P, Sadovskaya I, Ragunah C, Ramasubbu N, Kaplan JB, Jabbouri S (2007) Susceptibility of staphyloccal biofilms to enzymatic treatments depends on their chemical composition. Appl Microbiol Biotechnol 75 (1): 125-132
15. Curtin JJ, Donlan RM (2006) Using bacteriophages to reduce formation of catheter-associated biofilms by Staphylococcus epidermidis. Antimicrob Agents Chemother 50: 1268-1275
16. Darouiche R (2001) Device-associated infections: a macroproblem that starts with microadherence. Clin Infect Dis 22: 1567-1572
17. Darouiche RO, Mansouri MD, Gawande PV et al (2009) Antimicrobial and antibiofilm efficacy of triclosan and DispersinB combination. J Antimicrob Chemother 64: 88-93
18. Donlan R (2001) Biofilm formation: a clinically relevant microbiologic process. Clin Infect Dis 33: 1387-1392
19. Doolittle MM, Cooney JJ, Caldwell DE (1996) Tracing the interaction of bacteriophage with bacterial biofilms using fluorescent and chromogenic probes. J Ind Microbiol 16: 331-341
20. Drinkovic D, Morris AJ, Pottumarthy S, MacCulloch D, West T (2003) Bacteriological outcome of combination versus single-agent treatment for staphylococcal endocarditis. J Antimicrob Chemother 52 (5): 820
21. Dunne W, Burd E (1992) The effects of magnesium, calcium, EDTA, and pH on the in vitro adhesion of Staphylococcus epidermidis to plastic. Microbiol Immunol 36: 1019-1027
22. Fu W, Forster T, Mayer O, Curtin JJ, Lehman SM, Donlan RM (2010) Bacteriophage cocktail for the prevention of biofilm formation by Pseudomonas aeruginosa on catheters in an in vitro model system. Antimicrob Agents Chemother 54: 397-404
23. Gomez J, Canovas E, Banos V, Martinez L, Garcia E, Hernandez-Torres A, Canteras M, Ruiz J, Martinez P, Canovas A, Soriano A, Clavel M (2011) Linezolid plus rifampin as a salvage therapy in prosthetic joint infections treated without removing the implant. Antimicrob Agents Chemother 55 (9): 4308-4310
24. Hoiby N, Bjarnsholt T, Givskov M, Molin S, Ciofu O (2010) Antibiotic resistance of bacterial biofilms. Int J Antimicrob Agents 35: 322-332
25. Jonas M, Cunha BA (1982) Minocycline. Ther Drug Monit 4: 137-145
26. Kaplan JB (2009) Therapeutic potential of biofilmdispersing enzymes. Int J Artif Organs 32: 545-554
27. Karchmer AW, Archer GL, Dismukes WE (1983) Staphylococcus epidermidis causing prosthetic valve endocarditis: microbiologic and clinical observations as guides to therapy. Ann Intern Med 98 (4): 447
28. Kim SG, Yoon YH, Choi JW, Rha KS, Park YH (2012) Effect of furanone on experimentally induced Pseudomonas aeruginosa biofilm formation: in vitro study. Int J Pediatr Otorhinolaryngol 76 (11): 1575-1578
29. Kimura K, Itoh Y (2004) Characterization of polygamma-glutamate hydrolase encoded by a bacteriophage genome: possible role in phage infection of Bacillis subtilis encapsulated with poly-gammaglutamate. Appl Environ Microbiol 69 (5): 2491-2497
30. Lawson M, Hoth K, DeForest C, Bowman C, Anseth K (2010) Inhibition of Staphylococcus epidermidis biofilms using polymerizable vancomycin derivatives. Clin Orthop Rel Res 468: 2081-2091
31. Leite B, Gomes F, Teixeira P, Souza C, Pizzolitto E, Oliveira R (2011) In vitro activity of daptomycin, linezolid and rifampicin on Staphylococcus epidermidis biofilms. Curr Microbiol 63: 313-317
32. Maestre JR, Agular K, Mateo M, Gimenez MJ, Mendez ML, Alou L, Granizo JJ, Prieto J (2012) In vitro interference of tigecycline at subinhibitory concentrations on biofilm development by Enterococcus faecalis. J Antimicrob Chemother 67 (5): 1155-1158
33. Mah TC, O’Toole GA (2001) Mechanisms of biofilm resistance to antimicrobial agents. Trends Microbiol 9: 34-39
34. Marti M, Trotonda MP, Tormo-Mas MA, Vergara-Irigaray M, Cheung AL, Lasa I, Penades JR (2010) Extracellular proteases inhibit protein-dependent biofilm formation in Staphylococcus aureus. Microbes Infect 12 (1): 55-64
35. Meije Y, Almirante B, Del Pozo JL, Martin MT, Fernandez-Hidalgo N, Shan A, Basas J, Pahissa A, Gavalda J (2014) Daptomycin is effective as antibiotic-lock therapy in a model of Staphylococcus aureus catheter-related infection. J Infect S0163-4453 (14): 00004-00008
36. Meng X, Shi Y, Meng X, Zhang J, Wang H, Lu C, Sun J, Yan Y (2011) Application of a bacteriophage lysin to disrupt biofilms formed by the animal pathogen Streptococcus suis. Appl Environ Microbiol 77 (23): 8272-8279
37. Mermel LA, Allon M, Bouza E, Craven DE, Flynn P, O’Grady NP, Raad II, Rijnders BJ, Sherertz RJ, Warren DK (2009) Clinical practice guidelines for the diagnosis and management of intravascular catheter related infection: 2009 update by the Infectious Diseases Society of America. Clin Infect Dis 49: 1-45
38. Minardi D, Cirioni O, Ghiselli R, Silvestri C, Mocchegiani F, Gabrielli E, d’anzeo G, Conti A, Orlando F, Rimini M, Brescini L, Guerrieri M, Giaccometti A, Muzzonigro G (2012) Efficacy of tigecycline and rifampine alone and in combination against Enterococcus faecalis biofilm infection in a rat model of ureteral stent. J Surg Res 176 (1): 1-6
39. Moellering RC (2003) Linezolid: the first oxazolidinone antimicrobial. Ann Intern Med 138: 135-142
40. Niska JA, Shahbazian JH, Ramos RI, Pribaz JR, Billi F, Francis KP, Miller LS (2012) Daptomycin and tigecycline have broader effective dose ranges than vancomycin as prophylaxis against a Staphylococcus aureus surgical implant infection in mice. Antimicrob Agents Chemother 56 (5): 2590-2597
41. Percival SL, Kite P, Eastwood K, Murga R, Carr J, Arduino MJ, Donlan RM (2005) Tetrasodium EDTA as a novel central venous catheter lock solution against biofilm. Infect Control Hosp Epidemiol 26 (6): 515-519
42. Peterson LR (2008) A review of tigecycline-the first glycylcycline. Int J Antimicrob Agents 32: S215-S222
43. Projan SJ (2000) Preclinical pharmacology of GAR-936, a novel glycylcycline antibacterial agent. Pharmacotherapy 20: 219S-223S. Discussion 224S-228S
44. Raad I, Hachem R, Tcholakian R et al (2002) Efficacy of minocycline and EDTA lock solution in preventing catheter-related bacteremia, septic phlebitis, and endocarditis in rabbits. Antimicrob Agents Chemother 46: 327-332
45. Raad I, Hanna H, Jiang Y, Dvorak T, Reitzel R, Chaiban G et al (2007) Comparative activities of daptomycin, linezolid, and tigecycline against catheter-related methicillin-resistant staphylococcus bacteremic isolates embedded in biofilm. Antimicrob Agents Chemother 51: 1656-1660
46. Raad I, Fang X, Keutgen XM, Jiang Y, Sheretz R, Hachem R (2008) The role of chelators in preventing biofilm formation and catheter-related bloodstream infections. Curr Opin Infect Dis 21: 385-392
47. Richards JJ, Melander C (2009) Controlling bacterial biofilms. ChemBioChem 10: 2287-2294
48. Rogers SA, Huigens RW, Melander C (2009) A 2-aminobenzimidazole that inhibits and disperses Gram-positive biofilms through a zinc dependent mechanism. J Am Chem Soc 131: 9868-9869
49. Rogers SA, Huigens RW III, Cavanagh J, Melander C (2010) Synergistic effects between conventional antibiotics and 2-aminoimidazole-derived antibiofilm agents. Antimicrob Agents Chemother 54 (5): 2112-2118
50. Sarkisova S, Patrauchan M, Berglund D et al (2005) Calcium-induced virulence factors associated with the extracellular matrix of mucoid Pseudomonas aeruginosa biofilms. J Bacteriol 187: 4327-4337
51. Schaad HJ, Bento M, Lew DP, Vaudaux P (2006) Evaluation of high-dose daptomycin for therapy of experimental Staphylococcus aureus foreign body infection. BMC Infect Dis 6: 74
52. Schnappinger D, Hillen W (1996) Tetracyclines: antibiotic action, uptake, and resistance mechanisms. Arch Microbiol 165: 359-369
53. Sczuka E, Kaznowski A (2014) Antimicrobial activity of tigecycline alone or in combination with rifampin against Staphylococcus epidermidis in biofilm. Folia Microbiol 59: 283-288
54. Silverman JA, Perlmutter NG, Shapiro HM (2003) Correlation of daptomycin bactericidal activity and membrane depolarization in Staphylococcus aureus. Antimicrob Agents Chemother 47: 2538-2544
55. Simonetti O, Cirioni O, Mocchegiani F, Cacciatore I, Silvestri C, Baldassarre L, Orlando F, Castelli P, Proviniciali M, Vivarelli M, Fornasari E, Giacometti A, Offidani A (2013) The efficacy of the quorum sensing inhibitor FS8 and Tigecycline in preventing prosthesis biofilm in an animal model of staphylococcal infection. Int J Mol Sci 14: 16321-16332
56. Smilack JD (1999) The tetracyclines. Mayo Clin Proc 74: 727-729
57. Smith HW, Huggins MB (1982) Successful treatment of experimental Escherichia coli infections in mice using phage: its general superiority over antibiotics. J Gen Microbiol 128: 307-318
58. Swaney SM, Aoki H, Ganoza MC, Shinabarger DL (1998) The oxazolidinoe linezolid inhibits initiation of protein synthesis in bacteria. Antimicrob Agents Chemother 42 (12): 3251-3255
59. Tsaganos T, Skiadas I, Koutoukas P, Adamis T, Baxevanos N, Tzepi I, Pelekanou A, Giamarellos-Bourboulis EJ, Giamarellou H, Kanellakopoulou K (2008) Efficacy and pharmacodynamics of linezolid, alone and incombination with rifampicin, in an experimental model of methicillin-resistant Staphylococcus aureus endocarditis. J Antimicrob Chemother 62 (2): 381-383
60. Weinberg E (2004) Suppression of bacterial biofilm formation by iron limitation. Med Hypotheses 63: 863-865
61. Wu H, Song SZ, Hentzer M, Andersen JB, Molin S, Givskov M, Hoiby N (1998) Synthetic furanones inhibit quorum-sensing and enhance bacterial clearance in Pseudomonas aeruginosa lung infection in mice. J Antimicrob Chemother 53: 1054-1061
62. Zavasky DM, Sande MA (1998) Reconsideration of rifampin: a unique drug for a unique infection. JAMA 279: 1575-1577